Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataract | 6 | 2024 | 240 | 1.310 |
Why?
|
| Visual Acuity | 5 | 2025 | 499 | 1.050 |
Why?
|
| Phacoemulsification | 2 | 2023 | 124 | 0.880 |
Why?
|
| Geographic Atrophy | 4 | 2026 | 105 | 0.810 |
Why?
|
| Dementia | 1 | 2023 | 324 | 0.580 |
Why?
|
| Tomography, Optical Coherence | 5 | 2026 | 283 | 0.510 |
Why?
|
| Fluorescein Angiography | 3 | 2026 | 197 | 0.450 |
Why?
|
| Motion Pictures | 2 | 2026 | 21 | 0.440 |
Why?
|
| Diabetic Retinopathy | 2 | 2023 | 211 | 0.330 |
Why?
|
| Eyeglasses | 1 | 2026 | 27 | 0.240 |
Why?
|
| Cataract Extraction | 2 | 2024 | 120 | 0.230 |
Why?
|
| Intraoperative Complications | 2 | 2024 | 157 | 0.230 |
Why?
|
| Fovea Centralis | 1 | 2025 | 24 | 0.230 |
Why?
|
| Myopia | 2 | 2024 | 59 | 0.220 |
Why?
|
| Wet Macular Degeneration | 1 | 2025 | 63 | 0.210 |
Why?
|
| Strabismus | 1 | 2024 | 71 | 0.200 |
Why?
|
| Diseases in Twins | 1 | 2024 | 115 | 0.200 |
Why?
|
| Photorefractive Keratectomy | 1 | 2024 | 21 | 0.200 |
Why?
|
| Lasers, Excimer | 1 | 2024 | 30 | 0.200 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2024 | 20 | 0.200 |
Why?
|
| Refraction, Ocular | 1 | 2024 | 47 | 0.200 |
Why?
|
| Twins | 1 | 2024 | 156 | 0.200 |
Why?
|
| Aged, 80 and over | 6 | 2026 | 8391 | 0.200 |
Why?
|
| Macular Degeneration | 1 | 2025 | 196 | 0.190 |
Why?
|
| Macular Edema | 1 | 2023 | 49 | 0.190 |
Why?
|
| Methylprednisolone | 1 | 2023 | 58 | 0.190 |
Why?
|
| Complement System Proteins | 1 | 2026 | 326 | 0.190 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 142 | 0.190 |
Why?
|
| Optic Neuritis | 1 | 2023 | 44 | 0.190 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 137 | 0.190 |
Why?
|
| Insulins | 1 | 2023 | 39 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2024 | 103 | 0.180 |
Why?
|
| Retinopathy of Prematurity | 1 | 2024 | 183 | 0.180 |
Why?
|
| Lens, Crystalline | 1 | 2024 | 136 | 0.180 |
Why?
|
| Complement Activation | 1 | 2025 | 412 | 0.180 |
Why?
|
| Registries | 3 | 2025 | 2400 | 0.180 |
Why?
|
| Retinal Perforations | 1 | 2022 | 18 | 0.180 |
Why?
|
| Ophthalmology | 1 | 2023 | 122 | 0.170 |
Why?
|
| Birth Weight | 1 | 2024 | 521 | 0.170 |
Why?
|
| Follow-Up Studies | 6 | 2026 | 5439 | 0.170 |
Why?
|
| Retinal Detachment | 1 | 2022 | 74 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3034 | 0.160 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17438 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 2623 | 0.140 |
Why?
|
| Aged | 7 | 2026 | 26432 | 0.130 |
Why?
|
| Biomarkers | 2 | 2026 | 4340 | 0.120 |
Why?
|
| Algorithms | 1 | 2024 | 1849 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2024 | 1210 | 0.110 |
Why?
|
| Fundus Oculi | 2 | 2025 | 89 | 0.110 |
Why?
|
| Humans | 17 | 2026 | 146342 | 0.100 |
Why?
|
| Female | 11 | 2026 | 79499 | 0.100 |
Why?
|
| Male | 10 | 2026 | 73396 | 0.100 |
Why?
|
| Disease Progression | 3 | 2026 | 2867 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2024 | 11821 | 0.090 |
Why?
|
| Middle Aged | 5 | 2025 | 36619 | 0.090 |
Why?
|
| Risk Factors | 4 | 2025 | 10921 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2026 | 8123 | 0.070 |
Why?
|
| Axial Length, Eye | 1 | 2024 | 17 | 0.050 |
Why?
|
| Lens Diseases | 1 | 2024 | 3 | 0.050 |
Why?
|
| Refractive Errors | 1 | 2024 | 36 | 0.050 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2024 | 81 | 0.050 |
Why?
|
| Neuroprotection | 1 | 2023 | 46 | 0.050 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2023 | 145 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2023 | 496 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2023 | 129 | 0.040 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2022 | 80 | 0.040 |
Why?
|
| Gestational Age | 1 | 2024 | 990 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1331 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 2092 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 3017 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 561 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2861 | 0.030 |
Why?
|
| Child | 2 | 2026 | 22693 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 7109 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3647 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 5899 | 0.030 |
Why?
|
| Colorado | 1 | 2024 | 4595 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 6460 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 6073 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 3200 | 0.020 |
Why?
|